Literature DB >> 34269603

Evaluation of a Clinic Dedicated to People Aging with HIV at Chelsea and Westminster Hospital: Results of a 10-Year Experience.

Branca Pereira1,2, Maria Mazzitelli1,3, Ana Milinkovic1, Christina Casley1, Javier Rubio1, Rachel Channa1, Nicolo Girometti1, David Asboe1, Anton Pozniak1, Marta Boffito1,2.   

Abstract

Successful management of HIV infection as a chronic condition has resulted in a demographic shift where the proportion of people living with HIV (PLWH) older than 50 years is steadily increasing. A dedicated clinic to PLWH older than 50 years was established at Chelsea and Westminster Hospital in January 2009 and then extended to HIV services across the directorate. We report the results of a service evaluation reviewing 10 years of activities of this clinic between January 2009 and 2019. We aimed to estimate the prevalence of major noninfectious comorbidities, polypharmacy (≥5 medications), and multimorbidity (≥2 non-HIV-related comorbidities) and describe algorithms devised for use in HIV outpatient clinics across the directorate. A cohort of 744 PLWH older than 50 years attending this service were analyzed (93% male; mean age of 56 ± 5.5 years; 84% white ethnicity); 97.7% were on antiretroviral treatment and 95.9% had undetectable HIV-RNA at the time of evaluation. The most common comorbidities diagnosed were dyslipidemia (50.1%), hypertension (21.5%), mental health disorders (depression and/or anxiety disorders, 15.7%), osteoporosis (12.2%), obesity (11.9%), chronic kidney disease (7.5%), and diabetes (5.8%). Low vitamin D levels were found in 62% of patients [43% with vitamin D deficiency (<40 mmol/liter) and 57% with vitamin D insufficiency (40-70 mmol/liter)]. The overall prevalence of polypharmacy and multimorbidity was 46.6% and 69.3%, respectively. This study showed significant rates of non-HIV-related comorbidities and polypharmacy in PLWH older than 50 years, leading on to the implementation of clinical care pathways and new joint HIV/specialty clinics (cardiology, nephrology, neurology, metabolic, menopause, and geriatric) to improve prevention, diagnosis, and management of major comorbidities in people aging with HIV.

Entities:  

Keywords:  HIV; aging; comorbidities; frailty; pathways of care; polypharmacy

Mesh:

Year:  2021        PMID: 34269603     DOI: 10.1089/AID.2021.0083

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  3 in total

1.  Weight of Clinical and Social Determinants of Metabolic Syndrome in People Living with HIV.

Authors:  Mazzitelli Maria; Fusco Paolo; Brogna Michele; Vallone Alfredo; D'Argenio Laura; Beradelli Giuseppina; Foti Giuseppe; Mangano Carmelo; Carpentieri Maria Stella; Cosco Lucio; Scerbo Paolo; Priamo Armando; Serrao Nicola; Mastroianni Antonio; Costa Chiara; Tassone Maria Teresa; Vincenzo Scaglione; Francesca Serapide; Trecarichi Enrico Maria; Torti Carlo
Journal:  Viruses       Date:  2022-06-20       Impact factor: 5.818

2.  Real life use of dolutegravir doravirine dual regimen in experienced elderly PLWH with multiple comorbidities and on polypharmacy: A retrospective analysis.

Authors:  Maria Mazzitelli; Lolita Sasset; Davide Leoni; Cristina Putaggio; Anna Maria Cattelan
Journal:  Medicine (Baltimore)       Date:  2021-12-30       Impact factor: 1.889

3.  Strengths and Challenges of Various Models of Geriatric Consultation for Older Adults Living With Human Immunodeficiency Virus.

Authors:  Amelia J Davis; Meredith Greene; Eugenia Siegler; Kathleen V Fitch; Sarah A Schmalzle; Alysa Krain; Jaime H Vera; Marta Boffito; Julian Falutz; Kristine M Erlandson
Journal:  Clin Infect Dis       Date:  2022-03-23       Impact factor: 20.999

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.